The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000795392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
10/06/2026
Date registered
Help: Date registered
2/07/2026
Date last updated
Help: Date last updated
14/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
2/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Understanding how footwear designed to reduce toe walking affects walking patterns and comfort in children with idiopathic toe walking or toe walking associated with autism
Scientific title
Understanding how footwear designed to reduce toe walking affects walking patterns and comfort in children with idiopathic toe walking or toe walking associated with autism
Additional trial identifiers [1] 317551 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
idiopathic toe walking 342298 0
toe walking associated with autism 342384 0
Condition category
Condition code
Musculoskeletal 338408 338408 0 0
Other muscular and skeletal disorders
Mental Health 338510 338510 0 0
Autistic spectrum disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention is a commercially available footwear (Brand name: Aerlos) design intended to reduce toe-walking gait by promoting heel contact during walking. The intervention footwear will be fitted to each participant according to manufacturer sizing recommendations and used only during the study assessment session.

The intervention will be delivered by members of the research team who have expertise in paediatric gait assessment, toe walking treatment and lower limb biomechanics, including paediatric podiatrists, physiotherapists and researchers experienced in gait analysis and footwear assessment.

The intervention will be delivered individually during a face-to-face assessment session at Monash University in a university-based gait laboratory. Each participant will complete walking trials under three conditions: barefoot, their usual footwear, and the intervention footwear. The order of conditions will be randomised.

Participants will attend a single assessment session lasting approximately 45 minutes with each condition expected to take up to 10 minutes with a wash out break of 5 minutes before each intervention being tested.

During the intervention footwear condition, participants will complete repeated walking trials until three usable gait recordings are obtained. Rest breaks will be provided as required.

Adherence will be monitored directly by the research team during the assessment session. Because the intervention is tested only during a supervised single-session assessment, no additional reminders or home monitoring procedures are required. Completion of all planned walking trials and successful fitting and tolerance of the intervention footwear will be recorded.
Intervention code [1] 334340 0
Treatment: Devices
Description of the comparator or control
Both barefoot walking and walking in participants' usual footwear act as within-subject comparators.
Control group
Active

Outcomes
Primary outcome [1] 345720 0
Feasibility
Timepoint [1] 345720 0
Recruitment - end of recruitment period. Completion - end of trial. Intervention - end of data collection session. Assessment - end of data collection session. Data completeness - end of trial. Acceptability - end of data collection session.
Primary outcome [2] 345723 0
Safety
Timepoint [2] 345723 0
Assessed at end of data collection session.
Secondary outcome [1] 463023 0
Proportion of steps demonstrating heel contact (%)
Timepoint [1] 463023 0
Assessed during data collection session
Secondary outcome [2] 463024 0
Heel strike at initial contact (%)
Timepoint [2] 463024 0
Assessed during data collection session
Secondary outcome [3] 463332 0
Gait velocity (m/sec)
Timepoint [3] 463332 0
Assessed during data collection session
Secondary outcome [4] 463333 0
Step length (cm)
Timepoint [4] 463333 0
Assessed during data collection session
Secondary outcome [5] 463334 0
Stance phase percentage/Swing phase percentage (%) assessed together as a composite secondary measure
Timepoint [5] 463334 0
Assessed during data collection session
Secondary outcome [6] 463335 0
Foot progression angle (degrees)
Timepoint [6] 463335 0
Assessed during data collection session
Secondary outcome [7] 463336 0
Ankle position during heel walking (degrees)
Timepoint [7] 463336 0
Assessed during data collection session

Eligibility
Key inclusion criteria
Are aged 4 to 8 years
Have idiopathic toe walking or toe walking associated with Autism Spectrum Disorder
Walk independently
Can follow simple instructions and answer simple questions
Can demonstrate heel-to-toe gait on request at least intermittently
Have sufficient ankle dorsiflexion to safely participate
Can walk continuously for up to 5 minutes
Minimum age
4 Years
Maximum age
8 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Children with:
Neurological or neuromuscular conditions affecting gait other than Autism Spectrum Disorder-associated toe walking
Lower limb pain preventing participation
Recent treatments likely to substantially alter gait (for example surgery or botulinum toxin injection)
Inability to safely complete repeated walking trials

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Latin square
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Latin Square Randomisation
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Analyses will be primarily descriptive and focused on feasibility outcomes. Continuous outcomes will be reported as means and standard deviations or medians and interquartile ranges, as appropriate. Individual participant responses across conditions will be presented graphically.
Progression criteria:
Green (proceed):
At least 8/10 participants complete all conditions
At least 80% of trials usable
Intervention footwear tolerated by at least 8/10 participants
No serious adverse events
Amber (modify protocol):
6–7/10 participants complete all conditions
60–79% usable trials
Minor footwear or protocol issues identified
Red (major redesign required):
Fewer than 6/10 participants complete all conditions
Fewer than 60% usable trials
Significant footwear tolerance, acceptability or safety concerns

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 322108 0
University
Name [1] 322108 0
Monash University
Country [1] 322108 0
Australia
Primary sponsor type
University
Name
Monash University
Address
Country
Australia
Secondary sponsor category [1] 325001 0
None
Name [1] 325001 0
Address [1] 325001 0
Country [1] 325001 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320637 0
Monash University Human Research Ethics Committee
Ethics committee address [1] 320637 0
Ethics committee country [1] 320637 0
Australia
Date submitted for ethics approval [1] 320637 0
03/07/2026
Approval date [1] 320637 0
30/09/2026
Ethics approval number [1] 320637 0
52823

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151130 0
Prof Cylie Williams
Address 151130 0
Monash University, Peninsula Campus, 47-49 Moorooduc Hwy, Frankston VIC, 3199
Country 151130 0
Australia
Phone 151130 0
+61390044344
Fax 151130 0
Email 151130 0
Contact person for public queries
Name 151131 0
Cylie Williams
Address 151131 0
Monash University, Peninsula Campus, 47-49 Moorooduc Hwy, Frankston VIC, 3199
Country 151131 0
Australia
Phone 151131 0
+61390044344
Fax 151131 0
Email 151131 0
Contact person for scientific queries
Name 151132 0
Cylie Williams
Address 151132 0
Monash University, Peninsula Campus, 47-49 Moorooduc Hwy, Frankston VIC, 3199
Country 151132 0
Australia
Phone 151132 0
+61390044344
Fax 151132 0
Email 151132 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Anyone

• Researchers
Conditions for requesting access:
• No requirements
What individual participant data might be shared?
• De-identified individual participant data:
• All outcomes data
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies exploring new research questions
• Studies testing whether findings can be repeated or confirmed
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Data repository: De-identified data will be posted on Monash University Bridges data repository site. The Chief investigator can be emailed for this link.

• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.